Latest News and Press Releases
Want to stay updated on the latest news?
-
BRENTWOOD, Tenn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), will change its ticker symbol on the NASDAQ Stock Exchange from “IMAC” to “BACK” at...
-
BRENTWOOD, Tenn., July 26, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
-
The Back Space sequential quarter traffic increased over 100% BRENTWOOD, Tenn., June 30, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces...
-
BRENTWOOD, Tenn., June 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the launch of retail healthcare products for optimal spinal health...
-
BRENTWOOD, Tenn., April 29, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the selection of two The Back Space locations in the Orlando...
-
The Company plans to add 20 locations in the next 12 months BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the...
-
Revenue increased 26% for quarter and 12% annually BRENTWOOD, Tenn., March 31, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative...
-
BRENTWOOD, Tenn, March 24, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the third and final cohort of its Phase 1 clinical...
-
Expansion plan leverages Walmart pilot to meet growing demand for spinal health and wellness BRENTWOOD, Tenn., March 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or...
-
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...